InvestorsHub Logo
Followers 29
Posts 2331
Boards Moderated 0
Alias Born 12/31/2004

Re: None

Wednesday, 10/28/2020 10:27:42 PM

Wednesday, October 28, 2020 10:27:42 PM

Post# of 175
10/22/20 Investor Update Seminar



Very exciting, good stuff.

If they can deliver on things in the works, I'm expecting a triple by the end of next year.

Viral Transport Media (VTM) - should start seeing deliveries in January

QAP's - sales have been increasing, should start seeing those numbers in upcoming quarterly reports. Also, new products being introduced as time goes on.

Antigens - steady business now, gross margins should start increasing beginning with next quarterly

All in all, if they can deliver, revenues should triple for fiscal 2021.

Plus, but a big IF, is Kinlytic Urokinase. They are trying to secure a partner, and once done, 2 1/2 to 3 1/2 years for commercialization and sales, potentially $250M/yr share of the market. Not sure what percentage of that falls to Microbix, but would be substantial.